Carbon dioxide is one of the main drivers of climate change – which means that we need to reduce Carbon dioxide emissions in the future. Fraunhofer researchers are highlighting a possible way to lower these emissions: They use the greenhouse gas as a raw material, for instance to produce pl ... more
Dr. Kai Sohn
Fraunhofer-Institut für Grenzflächen- und Bioverfahrenstechnik (IGB)
Kai Sohn, born in 1968, studied biology at Heidelberg University and graduated with a diploma degree. He received his doctorate in 1997 from the Biochemistry Center of Heidelberg University. From 1998, Dr. Sohn worked as a postdoctoral researcher at the University of Stuttgart on medically relevant fungal pathogens. He then established his own research group Functional Genomics at the Fraunhofer IGB. Dr. Sohn is also a co-founder of the company Noscendo GmbH, which is active in the field of next generation diagnostics for infectious diseases. Dr. Sohn is now Head of Innovation Field In-vitro Diagnostics at Fraunhofer IGB.
Dr. Kai Sohn heads the Innovation Field In-vitro Diagnostics. He is a biochemistry lecturer at the medical faculty of Heidelberg University, as well as a reviewer for numerous international biomedical journals.
For their innovative diagnostic approach in the project “Next Generation Sequencing based Pathogen Diagnostics for Sepis”, Dr. Sohn and his team, together with partners from Heidelberg University Hospital, were awarded the 2019 Innovation Prize of the Stuttgart Intensive Care Conference (SIK).
Basing his work on the analysis of nucleic acids, Dr. Kai Sohn focuses on establishing and developing diagnostic applications in the fields of medicine, environment and sustainable chemistry. This includes combining high-throughput sequencing methods with the latest bioinformatics techniques.